FOIA: OHRP Investigation – Brigham and Woment’s Hospital
FOIA: OHRP Investigation – Brigham and Women’s Hospital Letter page one: Letter page 2: Letter page 3:
-
-
Artificial Heart Implant Leads to Suit Over Consent Process
Artificial Heart Implant Leads to Suit Over Consent Process Recipient’s Widow Says She and Her Husband Were Misinformed and Misled on Risks, Benefits By Debbie Goldberg Special to The Washington Post Saturday, November 30, 2002; Page A03 http://www.washingtonpost.com/ac2/wp-dyn/A54921-2002Nov29?language=printerwashingtonpost.com PHILADELPHIA, Nov. 25 — When James Quinn, a 51-year-old Vietnam veteran dying…
-
Bitter Medicine: Pills, Profit & the Public Health – ABC News
Date: Thu, 30 May 2002 14:14:47 -0400 From: Vera Subject: Bitter Medicine: Pills, Profit & the Public Health_ABC News ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) A Human Rights Organization www.researchprotection.org Contact: Vera Hassner Sharav FYI On May 17 The Wall Street Journal reported (in a front page article) that drug…
-
Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ
Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ Fri, 29 Jul 2005 The Wall Street Journal uncritically reported: “The results of the largest studies ever conducted of depression and schizophrenia will be released in coming months, potentially transforming the way patients are treated and shaking…
-
Ct. Attorney General Files Petition with FDA Seeking Warning on Drug – NYT
Ct. Attorney General Files Petition with FDA Seeking Warning on Drug – NYT Sat, 7 May 2005 Connecticut’s Attorney General, Richard Blumenthal, is to be commended for filing a citizen’s petition that essentially asks the FDA to do its job of protecting the public by issuing warnings about the potentially…
-
Unhealthy Ethics? The Price of NIH Credibility_ Editorials: WashPost / Los Angeles Times
Unhealthy Ethics? The Price of NIH Credibility_ Editorials: WashPost / Los Angeles Times Mon, 11 Apr 2005 Compare and contrast two editorials that focus on the new conflict of interest rules that were adopted by Dr. Elias Zerhouni, director of the National Institutes of Health, to rein in the corrupting…
-
Pfizer Statements RE: Bextra, Celebrex, Neurontin Shown to be Lies
Pfizer Statements RE: Bextra, Celebrex, Neurontin Shown to be Lies Fri, 08 Apr 2005 The New York Times reports that “as recently as Tuesday [Pfizer] assured Wall Street that sales of Celebrex and Bextra would soon rebound. It was the latest in a string of announcements by the company regarding…
-
NIH Chief Calls for Ethics Summit to address Conflicts of Interest in Medical Research – LA Times
NIH Chief Calls for Ethics Summit to address Conflicts of Interest in Medical Research – LA Times Mon, 14 Feb 2005 AHRP applauds Dr. Elias Zerhouni, director of the National Institutes of Health, for stepping up to the plate as a leader of an agency that will award about $21…
-
Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America – Whitaker
Anatomy of an Epidemic: Psychiatric Drugs and the Astonishing Rise of Mental Illness in America by Robert Whitaker, Ethical Human Psychology and Psychiatry, Volume 7, Number I , Spring 2005 Mon, 29 Aug 2005 Some uncritical promoters of psychiatry and its current biological treatment paradigm have declared that the introduction…
-
Tamiflu Cited in 2 Teen Deaths – Global Plan for Influenza Action – Lancet
Tamiflu Cited in 2 Teen Deaths – Global Plan for Influenza Action – Lancet Monday, November 14, 2005 Japanese newspapers report that two teenage boys – one 14 the other 17 – died after taking one dose of the antiviral drug, Tamiflu, the drug being stockpiled in the event that…
-
FDA acknowledges failure to act as defibrillator malfunction increased
FDA acknowledges failure to act as defibrillator malfunction increased: 4,225 failed between 2000–2003 Sat, 17 Sep 2005 The Washington Post reports that the number of failed heart defibrillators is increasing: “William H. Maisel, the Harvard Medical School physician who conducted the FDA study, said the increase is significant and contrasts…
-
Cognititve Therapy Halves Risk of Second Suicide Attempt – JAMA
Cognititve Therapy Halves Risk of Second Suicide Attempt – JAMA Tue, 6 Sep 2005 A study tested the effect of cognitive therapy in reducing the risk of a second suicide attempt by following 120 people who had attempted suicide. They were followed for 18 months–far longer than drug trials. According…